Physician profile
Jack M Becker
NPI 1851349955
$9,816.62
in general payments reported to CMS, 2019-2025
34 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $463 · 2021: $2,452 · 2022: $1,303 · 2023: $1,184 · 2024: $1,496 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,483 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,483.27 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $2,157.29 | 2019-2025 | Xolair |
| Astrazeneca Pharmaceuticals Lp | $1,384.67 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Regeneron Healthcare Solutions, INC. | $903.40 | 2019-2024 | Dupixent |
| Glaxosmithkline, LLC. | $887.61 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Genzyme Corporation | $610.01 | 2019-2025 | |
| Pfizer INC. | $533.82 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $423.59 | 2020-2025 | |
| Kaleo, INC. | $394.59 | 2019-2024 | Auvi-Q |
| Optinose US, INC. | $334.95 | 2019-2025 | |
| Incyte Corporation | $278.49 | 2021-2025 | Opzelura |
| Covis Pharma Gmbh | $223.12 | 2021-2022 | |
| Amgen INC. | $190.45 | 2022-2025 | Tezspire |
| Csl Behring | $165.02 | 2022-2025 | Haegarda, Andembry |
| Ars Pharmaceuticals Operations, INC. | $163.81 | 2025 | Neffy |
| Abbvie INC. | $161.21 | 2022-2023 | Rinvoq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $115.37 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $106.29 | 2020-2021 | |
| Biocryst US Sales Co., LLC | $97.93 | 2022-2023 | Orladeyo |
| Takeda Pharmaceuticals U.S.A., INC. | $95.16 | 2021-2025 | Takhzyro |
| Organon LLC | $92.35 | 2025 | Vtama |
| Alk-Abello, INC | $84.65 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Blueprint Medicines Corporation | $66.84 | 2023-2024 | Ayvakit |
| Merck Sharp & Dohme LLC | $57.07 | 2019-2023 | |
| Aimmune Therapeutics, INC. | $44.62 | 2021-2022 | |
| Greer Laboratories, INC. | $37.87 | 2025 | Oralair |
| Lilly USA, LLC | $36.47 | 2024-2025 | Ebglyss, Taltz |
| Phadia US INC. | $33.23 | 2021 | |
| Leo Pharma INC. | $32.00 | 2022-2023 | Adbry |
| Paratek Pharmaceuticals, INC. | $22.52 | 2025 | Xhance |
| Circassia INC. | $19.69 | 2019 | |
| Eyevance Pharmaceuticals LLC | $16.39 | 2020 | |
| Philips North America LLC | $15.79 | 2025 | Vest Therapy Und |
| Aytu Biopharma, INC. | $15.64 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.